Dashboard
Manage Tickers

ZYME Zymeworks Inc.

Nasdaq zymeworks.com


$ 22.82 $ 0.00 (0 %)    

Thursday, 20-Nov-2025 07:44:43 EST
CLICK TO SEE RELEVANT LITIGATION UPDATES
QQQ $ 610.80 $ 0.00 (0 %)
DIA $ 464.87 $ 0.00 (0 %)
SPY $ 671.48 $ 0.00 (0 %)
TLT $ 88.83 $ 0.00 (0 %)
GLD $ 375.72 $ 0.00 (0 %)
$ 22.6
$ 22.99
$ 21.96 x 5
$ 22.80 x 30
-- - --
$ 9.03 - $ 26.19
1,938,163
na
1.42B
$ 1.08
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 11-06-2025 09-30-2025 10-Q
2 08-07-2025 06-30-2025 10-Q
3 05-08-2025 03-31-2025 10-Q
4 03-05-2025 01-01-1970 10-K
5 10-31-2024 09-30-2024 10-Q
6 08-01-2024 06-30-2024 10-Q
7 05-02-2024 03-31-2024 10-Q
8 03-06-2024 12-31-2023 10-K
9 11-07-2023 09-30-2023 10-Q
10 08-10-2023 06-30-2023 10-Q
11 05-08-2023 03-31-2023 10-Q
12 03-07-2023 12-31-2022 10-K
13 11-08-2022 09-30-2022 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

wells-fargo-maintains-equal-weight-on-zymeworks-raises-price-target-to-25
Wells Fargo Maintains Equal-Weight on Zyme...
11/19/2025 14:08:04

Wells Fargo analyst Eva Fortea Verdejo maintains Zymeworks (NASDAQ:ZYME) with a Equal-Weight and raises the price target fro...

stifel-maintains-buy-on-zymeworks-raises-price-target-to-40
Stifel Maintains Buy on Zymeworks, Raises ...
11/19/2025 12:53:32

Stifel analyst Stephen Willey maintains Zymeworks (NASDAQ:ZYME) with a Buy and raises the price target from $30 to $40.

alphabet-to-rally-more-than-12-here-are-10-top-analyst-forecasts-for-tuesday
Alphabet To Rally More Than 12%? Here Are ...
11/18/2025 12:34:04

hc-wainwright--co-maintains-buy-on-zymeworks-raises-price-target-to-32
HC Wainwright & Co. Maintains Buy on Zymew...
11/18/2025 11:10:52

HC Wainwright & Co. analyst Robert Burns maintains Zymeworks (NASDAQ:ZYME) with a Buy and raises the price target from $...

zymeworks-unveils-royalty-driven-strategic-initiative-following-positive-phase-3-herizon-gea-01-trial-results-for-ziihera-in-first-line-gea
Zymeworks Unveils Royalty Driven Strategic...
11/18/2025 06:43:26

Strategy will combine internal innovation, licensing, and strategic acquisitions to drive sustainable value creation for shareh...

zymeworks-jazz-pharmaceuticals-stocks-climb-on-robust-gastroesophageal-trial-outcomes-and-upcoming-regulatory-plans
Zymeworks, Jazz Pharmaceuticals Stocks Cli...
11/17/2025 17:09:52

Zymeworks rises after Ziihera shows significant PFS and OS benefits in a Phase 3 trial, supporting plans for regulatory filings...

12-health-care-stocks-moving-in-mondays-intraday-session
12 Health Care Stocks Moving In Monday's I...
11/17/2025 17:06:53

jazz-pharmaceuticals-sigma-lithium-zymeworks-and-other-big-stocks-moving-higher-on-monday
Jazz Pharmaceuticals, Sigma Lithium, Zymew...
11/17/2025 16:39:23

Core News & Articles
Market-Moving News for November 17th
11/17/2025 12:23:00

GOOG: 5% | Alphabet Inc shares are trading higher after Berkshire Hathaway disclosed a new stake in the company. ZYME: 61% | Zy...

12-health-care-stocks-moving-in-mondays-pre-market-session
12 Health Care Stocks Moving In Monday's P...
11/17/2025 12:06:42

Core News & Articles
Zymeworks And Partners Report Statisticall...
11/17/2025 11:18:46

Ziihera® plus chemotherapy showed a clinically meaningful and statistically significant improvement in PFS versus trastuzumab a...

wells-fargo-maintains-equal-weight-on-zymeworks-raises-price-target-to-17
Wells Fargo Maintains Equal-Weight on Zyme...
11/07/2025 18:54:52

Wells Fargo analyst Eva Fortea Verdejo maintains Zymeworks (NASDAQ:ZYME) with a Equal-Weight and raises the price target fro...

zymeworks-q3-eps-026-beats-035-estimate-sales-27614m-miss-29460m-estimate
Zymeworks Q3 EPS $(0.26) Beats $(0.35) Est...
11/06/2025 21:19:34

Zymeworks (NASDAQ:ZYME) reported quarterly losses of $(0.26) per share which beat the analyst consensus estimate of $(0.35) by ...

earnings-scheduled-for-november-6-2025
Earnings Scheduled For November 6, 2025
11/06/2025 11:12:19

5-analysts-have-this-to-say-about-zymeworks
5 Analysts Have This To Say About Zymeworks
10/24/2025 12:01:42

zymeworks-announces-preliminary-results-from-phase-1-study-evaluating-zw191-adc-targeting-folate-receptor-alpha-at-aacr-nci-eortc-conference
Zymeworks Announces Preliminary Results Fr...
10/23/2025 16:32:55

Preliminary efficacy data, combined with a tolerable safety profile, reinforce the potential of ZW191 in patients with advanced...

jp-morgan-maintains-overweight-on-zymeworks-raises-price-target-to-23
JP Morgan Maintains Overweight on Zymework...
10/16/2025 11:48:53

JP Morgan analyst Brian Cheng maintains Zymeworks (NASDAQ:ZYME) with a Overweight and raises the price target from $20 to $23.

broadcom-to-rally-more-than-12-here-are-10-top-analyst-forecasts-for-tuesday
Broadcom To Rally More Than 12%? Here Are ...
10/14/2025 12:25:08

this-rpm-international-analyst-turns-bullish-here-are-top-5-upgrades-for-tuesday
This RPM International Analyst Turns Bulli...
10/14/2025 12:00:55

hc-wainwright--co-upgrades-zymeworks-to-buy-raises-price-target-to-26
HC Wainwright & Co. Upgrades Zymeworks to ...
10/14/2025 11:15:14

HC Wainwright & Co. analyst Robert Burns upgrades Zymeworks (NASDAQ:ZYME) from Neutral to Buy and raises the price targe...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION